← FDA Drug Approvals (Drugs@FDA)
XENOVIEW
NDA · New Drug Application · Sponsor: POLAREAN · Approved 2022-12-23
Drug application
- FDA Application #
NDA214375- Application type
- New Drug Application
- Brand name
- XENOVIEW
- Generic name
- XENON XE 129 HYPERPOLARIZED
- Active ingredients
- XENON XE-129 HYPERPOLARIZED
- Dosage form
- GAS
- Route
- INHALATION
- Marketing status
- Prescription
- Sponsor
- POLAREAN
- Manufacturer
- Polarean, Inc.
- First approval
- 2022-12-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown